Company Data
FibroGen Inc
Ticker
FGEN
Current Price
$0.7059 -8.61%
Market Cap
$71.1M
Price Target
Refer to Report
Volume
9.4M
52wk Range
$0.18 - $2.8
Overview
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen’s revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company’s ability to advance product candidates.